Cargando…
New-Onset Type 1 Diabetes Mellitus After Treatment With Nivolumab for Melanoma
A 67-year-old female taking Nivolumab for melanoma developed a hyperglycemic emergency requiring hospital admission. She was referred to our endocrinology clinic post-discharge where she was diagnosed with new-onset Type 1 diabetes mellitus. Severe hyperglycemia and immune-mediated diabetes mellitus...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580131/ https://www.ncbi.nlm.nih.gov/pubmed/34786258 http://dx.doi.org/10.7759/cureus.18679 |